Contribution of BRCA1 and BRCA2 to Familial Ovarian Cancer: A Gynecologic Oncology Group Study

Author： Reedy M. Gallion H. Fowler J.M. Kryscio R. Smith S.A.

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.2, 2002-05, pp. : 255-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA1 Germline Mutations and Polymorphisms in a Clinic-Based Series of Ovarian Cancer Cases: A Gynecologic Oncology Group Study

By Smith S.A. Richards W.E. Caito K. Hanjani P. Markman M. DeGeest K. Gallion H.H.

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 586-592

Elsevier

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer

By Lheureux Stéphanie

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 885-891

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

By Son Byung

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1143-1152

Springer Publishing Company

Access to resources Recommend Favorite